...
armp-img

Armata Pharmaceuticals Inc, Common Stock

ARMP

ASQ

$2.14

-$0.06

(-2.73%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$79.60M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
3.93K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.81
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.98 L
$4.48 H
$2.14

About Armata Pharmaceuticals Inc, Common Stock

Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is headquartered in Los Angeles, California. Armata Pharmaceuticals, Inc. is a subsidiary of Innoviva, Inc. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameARMPSectorS&P500
1-Week Return-8.94%0.67%0.49%
1-Month Return-8.94%0.26%5.96%
3-Month Return-10.83%-6.21%9.35%
6-Month Return-22.18%1.69%14.4%
1-Year Return-21.32%11.41%32.23%
3-Year Return-52.44%12.87%33.15%
5-Year Return-50.46%48.89%95.23%
10-Year Return-99.81%109.26%191.11%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue31.00K823.00K4.47M5.51M4.53M[{"date":"2019-12-31","value":0.56,"profit":true},{"date":"2020-12-31","value":14.94,"profit":true},{"date":"2021-12-31","value":81.23,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":82.23,"profit":true}]
Cost of Revenue1.35M14.44M20.02M892.00K33.77M[{"date":"2019-12-31","value":4,"profit":true},{"date":"2020-12-31","value":42.77,"profit":true},{"date":"2021-12-31","value":59.27,"profit":true},{"date":"2022-12-31","value":2.64,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit(1.35M)(13.62M)(15.54M)4.62M(29.24M)[{"date":"2019-12-31","value":-29.27,"profit":false},{"date":"2020-12-31","value":-295.08,"profit":false},{"date":"2021-12-31","value":-336.68,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-633.47,"profit":false}]
Gross Margin(4358.06%)(1655.04%)(347.36%)83.81%(645.64%)[{"date":"2019-12-31","value":-5200.22,"profit":false},{"date":"2020-12-31","value":-1974.86,"profit":false},{"date":"2021-12-31","value":-414.49,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-770.4,"profit":false}]
Operating Expenses19.09M21.59M23.82M36.95M11.65M[{"date":"2019-12-31","value":51.67,"profit":true},{"date":"2020-12-31","value":58.43,"profit":true},{"date":"2021-12-31","value":64.48,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":31.53,"profit":true}]
Operating Income(19.75M)(21.59M)(23.82M)(36.95M)(40.89M)[{"date":"2019-12-31","value":-1975200000,"profit":false},{"date":"2020-12-31","value":-2158700000,"profit":false},{"date":"2021-12-31","value":-2382200000,"profit":false},{"date":"2022-12-31","value":-3694600000,"profit":false},{"date":"2023-12-31","value":-4089000000,"profit":false}]
Total Non-Operating Income/Expense(562.00K)(1.19M)608.00K58.00K(29.21M)[{"date":"2019-12-31","value":-92.43,"profit":false},{"date":"2020-12-31","value":-196.38,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":9.54,"profit":true},{"date":"2023-12-31","value":-4803.62,"profit":false}]
Pre-Tax Income(19.48M)(22.18M)(23.16M)(36.92M)(69.05M)[{"date":"2019-12-31","value":-1947900000,"profit":false},{"date":"2020-12-31","value":-2218100000,"profit":false},{"date":"2021-12-31","value":-2315500000,"profit":false},{"date":"2022-12-31","value":-3691700000,"profit":false},{"date":"2023-12-31","value":-6904500000,"profit":false}]
Income Taxes(454.00K)634.00K64.00K(29.00K)-[{"date":"2019-12-31","value":-71.61,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":10.09,"profit":true},{"date":"2022-12-31","value":-4.57,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes(19.02M)(22.82M)(23.22M)(36.89M)-[{"date":"2019-12-31","value":-1902500000,"profit":false},{"date":"2020-12-31","value":-2281500000,"profit":false},{"date":"2021-12-31","value":-2321900000,"profit":false},{"date":"2022-12-31","value":-3688800000,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]
Income From Continuous Operations(19.48M)(22.18M)(23.16M)(36.92M)(59.51M)[{"date":"2019-12-31","value":-1947900000,"profit":false},{"date":"2020-12-31","value":-2218100000,"profit":false},{"date":"2021-12-31","value":-2315500000,"profit":false},{"date":"2022-12-31","value":-3691700000,"profit":false},{"date":"2023-12-31","value":-5951200000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(19.02M)(22.82M)(23.22M)(36.89M)(69.05M)[{"date":"2019-12-31","value":-1902500000,"profit":false},{"date":"2020-12-31","value":-2281500000,"profit":false},{"date":"2021-12-31","value":-2321900000,"profit":false},{"date":"2022-12-31","value":-3688800000,"profit":false},{"date":"2023-12-31","value":-6904500000,"profit":false}]
EPS (Diluted)(3.31)(1.42)(0.97)(1.09)(1.80)[{"date":"2019-12-31","value":-331,"profit":false},{"date":"2020-12-31","value":-142,"profit":false},{"date":"2021-12-31","value":-97,"profit":false},{"date":"2022-12-31","value":-109,"profit":false},{"date":"2023-12-31","value":-180,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

ARMP
Cash Ratio 0.15
Current Ratio 0.19

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

ARMP
ROA (LTM) -25.09%
ROE (LTM) -3439.35%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

ARMP
Debt Ratio Lower is generally better. Negative is bad. 1.52
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -0.52

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

ARMP
Trailing PE NM
Forward PE NM
P/S (TTM) 21.40
P/B 4.06
Price/FCF NM
EV/R 148.14
EV/Ebitda NM

FAQs

What is Armata Pharmaceuticals Inc share price today?

Armata Pharmaceuticals Inc (ARMP) share price today is $2.14

Can Indians buy Armata Pharmaceuticals Inc shares?

Yes, Indians can buy shares of Armata Pharmaceuticals Inc (ARMP) on Vested. To buy Armata Pharmaceuticals Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ARMP stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Armata Pharmaceuticals Inc be purchased?

Yes, you can purchase fractional shares of Armata Pharmaceuticals Inc (ARMP) via the Vested app. You can start investing in Armata Pharmaceuticals Inc (ARMP) with a minimum investment of $1.

How to invest in Armata Pharmaceuticals Inc shares from India?

You can invest in shares of Armata Pharmaceuticals Inc (ARMP) via Vested in three simple steps:

  • Click on Sign Up or Invest in ARMP stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Armata Pharmaceuticals Inc shares
What is Armata Pharmaceuticals Inc 52-week high and low stock price?

The 52-week high price of Armata Pharmaceuticals Inc (ARMP) is $4.48. The 52-week low price of Armata Pharmaceuticals Inc (ARMP) is $1.98.

What is Armata Pharmaceuticals Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Armata Pharmaceuticals Inc (ARMP) is

What is Armata Pharmaceuticals Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Armata Pharmaceuticals Inc (ARMP) is 4.06

What is Armata Pharmaceuticals Inc dividend yield?

The dividend yield of Armata Pharmaceuticals Inc (ARMP) is 0.00%

What is the Market Cap of Armata Pharmaceuticals Inc?

The market capitalization of Armata Pharmaceuticals Inc (ARMP) is $79.60M

What is Armata Pharmaceuticals Inc’s stock symbol?

The stock symbol (or ticker) of Armata Pharmaceuticals Inc is ARMP

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top